Project Grant R43HD117483
Award Date
8/1/25
Completion Date
7/31/26
Dollars Obligated
$307K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Oregon, USA
Similar Awards
The National Institute of Child Health and Human Development (NICHD) awarded a $2,283,054 Project Grant under CFDA 93.865, the Child Health and Human Development Extramural Research program, to CX Therapeutics, Inc. The grant aims to advance a novel medical device for treating cervical insufficiency, a pregnancy complication that can lead to preterm birth. Through this Phase II award, CX Therapeutics will finalize the device design, complete engineering verification, validate the device's...
The National Institute of Child Health and Human Development (NICHD) awarded a $383,114 Small Business Innovation Research (SBIR) Phase I project grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Venova Technologies Inc., a women-led and minority-led medical device startup company. The grant funds the development of a novel, non-hormonal, long-acting female contraceptive device designed to address the critical unmet need for birth control options without hormonal...
The University of Health Sciences and Pharmacy in St. Louis received a $474,946 Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), to develop a novel, non-hormonal, female-initiated contraceptive device. The project aims to create a dual-compartment vaginal device that enables women to administer a contraceptive smart fiber mat and a...
The National Institute of Child Health and Human Development (NICHD) awarded a $304,906 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Little Room Innovations LLC, a for-profit medical device company located in Ann Arbor, Michigan. The grant supports the development and testing of a novel body-powered prosthetic terminal device with enhanced grasping capabilities for individuals with upper limb loss. The project aims to create a durable, high-strength...
This $380,692 Project Grant awarded by the National Institute of Child Health and Human Development (NICHD) under CFDA Program 93.865 (Child Health and Human Development Extramural Research) supports the development of an ultrapotent anti-sperm antibody construct for a non-hormonal contraceptive intravaginal ring. The funding will be used by Mucommune LLC, a biopharmaceutical company in Durham, North Carolina, to validate the safety and effectiveness of the LAMH10 antibody formulated into an...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $291,440 to Contraline, Inc. to support the development of ADAM AIR, a non-hormonal, vas-occlusive contraceptive device. The key products to be delivered through this funding are advancements to Contraline's existing ADAM contraceptive hydrogel technology. Specifically, the project aims to develop a...
The National Institute of Child Health and Human Development (NICHD) awarded a $413,843 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to The Pennsylvania State University, doing business as Penn State, to develop advanced biofabricated seminiferous tubules for in vitro spermatogenesis research. The proposed work aims to use micro-extrusion technology to precisely fabricate microtubes that mimic the cellular composition and organization of in vivo...
The Project Grant award R43HD115425 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) is supporting Theranova LLC, a veteran-owned medical device R&D company, to conduct a pilot clinical study evaluating the SOLESTIM neuromodulation system as a home-use treatment for dysmenorrhea (primary menstrual cramps). The $343,510 award will fund a 16-week,...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) provides $309,251 to Expanse Bio LLC to develop an ex vivo microfluidic organ perfusion device for long-term culture and assessment of whole ovaries. The goal is to create a more physiologically relevant model for evaluating the ovotoxicity (ovarian damage) potential of drug candidates, particularly...
This Project Grant award of $304,452 from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop a minimally invasive intrauterine labor augmentation system (ILAS) to directly increase labor forces and relieve uterine muscle demand during childbirth. The project objectives are to further develop the system's catheter-balloon component for safe prolonged intrauterine use, finalize the configuration and pleating pattern, and...